Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription factor. by S. Courapied et al.
Regulation of the Aurora-A gene following topoisomerase I
inhibition: implication of the Myc transcription factor.
Submitted by Sandrine Giraud on Thu, 03/05/2015 - 12:15
Titre Regulation of the Aurora-A gene following topoisomerase I inhibition: implication ofthe Myc transcription factor.
Type de
publication Article de revue
Auteur
Courapied, Sandy [1], Cherier, Julia [2], Vigneron, Arnaud [3], Troadec, Marie-
Bérangère [4], Giraud, Sandrine [5], Valo, Isabelle [6], Prigent, Claude [7], Gamelin,
Erik [8], Coqueret, Olivier [9], Barré, Benjamin [10]










Aurora Kinases [11], Base Sequence [12], Cell Line, Tumor [13], Chromatin
Immunoprecipitation [14], DNA Primers [15], DNA Topoisomerases, Type I [16],
Gene Expression Regulation, Enzymologic [17], Humans [18], Promoter Regions,




During the G2 phase of the cell cycle, the Aurora-A kinase plays an important role in
centrosome maturation and progression to mitosis. In this study, we show in
colorectal cell lines that Aurora-A expression is downregulated in response to
topoisomerase I inhibition. Using chromatin immunoprecipitation assays, we have
observed that the Myc transcription factor and its Max binding partner are
associated with the Aurora-A promoter during the G2 phase of the cell cycle. RNA
interference experiments indicated that Myc is involved in the regulation of the
Aurora-A gene. Following topoisomerase I inhibition, the expression of Myc
decreased whereas Mad was upregulated, and the association of Myc and Max with
the promoter of the kinase was inhibited. In parallel, an increased association of
Mad and Miz-1 was detected on DNA, associated with an inhibition of the
recruitment of transcriptional coactivators. Interestingly, a gain of H3K9
trimethylation and HP1gamma recruitment was observed on the Aurora-A promoter
following sn38 treatment, suggesting that this promoter is located within SAHF foci
following genotoxic treatment. Since Aurora-A is involved in centrosome maturation,
we observed as expected that topoisomerase I inhibition prevented centrosome
separation but did not affect their duplication. As a consequence, this led to G2
arrest and senescence induction.These results suggest a model by which the Aurora-
A gene is inactivated by the G2 checkpoint following topoisomerase I inhibition. We
therefore propose the hypothesis that the coordinated overexpression of Myc and
Aurora-A, together with a downregulation of Mad and Miz-1 should be tested as a
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